Business
Press Release Nov 10 2025
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Glenmark Secures China Approval For RYALTRIS®, Reinforcing Respiratory Innovation Leadership".
About this update from Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Glenmark Secures China Approval For RYALTRIS®, Reinforcing Respiratory Innovation Leadership". View Attachment
View stock analysis, news, and events for Glenmark Pharmaceuticals Limited